Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Genetic diagnosis of endocrine disorders in Cyprus through the Cyprus Institute of Neurology and Genetics: an ENDO-ERN Reference Center.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • المصدر:
      Publisher: BioMed Central Country of Publication: England NLM ID: 101266602 Publication Model: Electronic Cited Medium: Internet ISSN: 1750-1172 (Electronic) Linking ISSN: 17501172 NLM ISO Abbreviation: Orphanet J Rare Dis Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: [London] : BioMed Central, 2006-
    • الموضوع:
    • نبذة مختصرة :
      The report covers the current and past activities of the department Molecular Genetics-Function and Therapy (MGFT) at the Cyprus Institute of Neurology and Genetics (CING), an affiliated Reference Center for the European Reference Network on Rare Endocrine Conditions (Endo-ERN).The presented data is the outcome of > 15 years long standing collaboration between MGFT and endocrine specialists from the local government hospitals and the private sector. Up-to-date > 2000 genetic tests have been performed for the diagnosis of inherited rare endocrine disorders. The major clinical entities included Congenital Adrenal Hyperplasia (CAH) due to pathogenic variants in CYP21A2 gene and Multiple Endocrine Neoplasia (MEN) type 2 due to pathogenic variants in the RET proto-oncogene. Other rare and novel pathogenic variants in ANOS1, WDR11, FGFR1, RNF216, and CHD7 genes were also found in patients with Congenital Hypogonadotropic Hypogonadism. Interestingly, a few patients with Disorders of Sexual Differentiation (DSD) shared rare pathogenic variants in the SRD5A2, HSD17B3 and HSD3B2 while patients with Glucose and Insulin Homeostasis carried theirs in GCK and HNF1A genes. Lastly, MGFT over the last few years has established an esteemed diagnostic and research program on premature puberty with emphasis on the implication of MKRN3 gene on the onset of the disease and the identification of other prognosis biomarkers.As an Endo-ERN member MGFT department belongs to this large European network and holds the same humanistic ideals which aim toward the improvements of health care for patients with rare endocrine conditions in respect to improved and faster diagnosis.
      (© 2024. The Author(s).)
    • References:
      Int J Mol Sci. 2023 Nov 04;24(21):. (PMID: 37958948)
      N Engl J Med. 2020 Sep 24;383(13):1248-1261. (PMID: 32966723)
      Front Endocrinol (Lausanne). 2020 Aug 28;11:626. (PMID: 32982993)
      Genet Test. 2004 Summer;8(2):163-8. (PMID: 15345114)
      JAMA. 1996 Nov 20;276(19):1575-9. (PMID: 8918855)
      Hormones (Athens). 2011 Jul-Sep;10(3):230-5. (PMID: 22001134)
      Clin Biochem. 2009 Sep;42(13-14):1363-7. (PMID: 19501079)
      Endocrine. 2017 May;56(2):446-449. (PMID: 28132164)
      Horm Res Paediatr. 2011;75(3):180-6. (PMID: 20838032)
      J Pediatr Endocrinol Metab. 2020 Nov 11;34(1):131-136. (PMID: 33180036)
      Eur J Endocrinol. 2022 Mar 23;186(5):K17-K24. (PMID: 35235536)
      Clin Genet. 2019 Feb;95(2):320-324. (PMID: 30467832)
      Hormones (Athens). 2017 Jul;16(3):318-321. (PMID: 29278519)
      Eur J Endocrinol. 2010 Aug;163(2):301-8. (PMID: 20516206)
      J Endocrinol Invest. 2015 May;38(5):535-9. (PMID: 25481255)
      Front Endocrinol (Lausanne). 2019 Oct 04;10:677. (PMID: 31636607)
      Hormones (Athens). 2016 Apr;15(2):235-242. (PMID: 27376426)
      Clin Genet. 2013 Dec;84(6):585-8. (PMID: 23600966)
      Orphanet J Rare Dis. 2020 Jun 8;15(1):144. (PMID: 32513286)
      Front Endocrinol (Lausanne). 2023 Jan 13;13:1075341. (PMID: 36714607)
      Int J Mol Med. 2022 Jan;49(1):. (PMID: 34821371)
      Indian J Endocrinol Metab. 2014 Nov;18(Suppl 1):S72-9. (PMID: 25538881)
      Eur Thyroid J. 2013 Jan;1(4):216-31. (PMID: 24783025)
      J Clin Res Pediatr Endocrinol. 2018 Mar 1;10(1):74-78. (PMID: 28739554)
      Front Endocrinol (Lausanne). 2023 May 31;14:1156616. (PMID: 37324257)
      Clin Endocrinol (Oxf). 2016 Jan;84(1):80-4. (PMID: 26173472)
      Life (Basel). 2023 Jun 06;13(6):. (PMID: 37374115)
      J Steroid Biochem Mol Biol. 2020 Apr;198:105554. (PMID: 31805392)
      Endocr Connect. 2023 Jul 14;12(8):. (PMID: 37256668)
      Horm Metab Res. 2019 Sep;51(9):586-594. (PMID: 31505704)
      J Clin Res Pediatr Endocrinol. 2016 Jun 5;8(2):125-34. (PMID: 27086651)
      Clin Biochem. 2011 Aug;44(12):959-63. (PMID: 21635882)
      Lancet. 2023 Jan 21;401(10372):227-244. (PMID: 36502822)
      Thyroid. 2009 Jun;19(6):565-612. (PMID: 19469690)
      Hormones (Athens). 2016 Jul;15(3):445-452. (PMID: 27394708)
      Hormones (Athens). 2019 Sep;18(3):315-320. (PMID: 31240586)
      Eur J Hum Genet. 2020 Oct;28(10):1341-1367. (PMID: 32616876)
      J Endocrinol Invest. 2018 Oct;41(10):1149-1157. (PMID: 29396759)
      Gene. 2012 May 15;499(2):250-5. (PMID: 22445608)
      Hormones (Athens). 2023 Mar;22(1):71-77. (PMID: 36264454)
      Arch Endocrinol Metab. 2022 Apr 28;66(2):168-175. (PMID: 35289513)
      Georgian Med News. 2012 Sep;(210):40-7. (PMID: 23045419)
      Eur J Hum Genet. 2009 Feb;17(2):139-46. (PMID: 18985070)
      EMBO Mol Med. 2016 Jun 01;8(6):626-42. (PMID: 27137492)
      Front Endocrinol (Lausanne). 2021 Sep 24;12:745048. (PMID: 34630334)
      Thyroid. 2015 Jun;25(6):567-610. (PMID: 25810047)
      Int J Endocrinol. 2017;2017:8984365. (PMID: 28487735)
      J Endocrinol Invest. 2010 Dec;33(11):810-4. (PMID: 20511729)
      Metabolism. 2013 Nov;62(11):1535-42. (PMID: 23890519)
      Front Endocrinol (Lausanne). 2018 Dec 03;9:733. (PMID: 30559721)
      Proc Natl Acad Sci U S A. 2013 Feb 12;110(7):2611-6. (PMID: 23359698)
      J Endocrinol Invest. 2011 Nov;34(10):764-9. (PMID: 21422799)
    • Contributed Indexing:
      Keywords: MKRN3; RET; CAH; DSD; ENDO-ERN; Endocrine disorders; MEN2; MODY
    • الرقم المعرف:
      EC 2.3.2.27 (RNF216 protein, human)
      EC 2.3.2.27 (Ubiquitin-Protein Ligases)
      EC 2.3.2.27 (MKRN3 protein, human)
      EC 1.14.14.16 (CYP21A2 protein, human)
      EC 1.14.14.16 (Steroid 21-Hydroxylase)
      EC 1.3.99.5 (SRD5A2 protein, human)
      0 (Membrane Proteins)
      EC 1.3.99.5 (3-Oxo-5-alpha-Steroid 4-Dehydrogenase)
    • الموضوع:
      Date Created: 20240418 Date Completed: 20240422 Latest Revision: 20240426
    • الموضوع:
      20250114
    • الرقم المعرف:
      PMC11027394
    • الرقم المعرف:
      10.1186/s13023-024-03171-4
    • الرقم المعرف:
      38637882